The dose titration principle of dapoxetine hydrochloride and the support of the treatment effect evaluation system for personalized treatment

The principle of dose titration of dapoxetine hydrochloride emphasizes individualized treatment, and the medication regimen is adjusted according to the patient's specific situation and treatment response.For patients using dapoxetine for the first time, it is recommended to start with a dose of 30 mg and evaluate the therapeutic effect and tolerance after at least 4 doses.The evaluation of the therapeutic effect should include two dimensions: objective indicators and subjective feelings.Objective indicators mainly include the degree of prolongation of the latent time of vaginal ejaculation, and quantitative data are obtained through the patient's readme or timer record.Subjective feelings include the degree of improvement in ejaculation control ability, the evaluation of sexual intercourse satisfaction, and the reduction of psychological distress associated with premature ejaculation.Combining these evaluation information, the doctor can judge the suitability of the 30 mg dose for the patient.

For patients whose 30 mg dose is insufficient but well tolerated, consider increasing the dose to 60 mg.The dose increase needs to be carried out under the guidance of a doctor and cannot be adjusted by yourself.A dose of 60 mg may provide a stronger delayed ejaculation effect, but the incidence and severity of adverse reactions may also increase accordingly.Therefore, after dose adjustment, it is necessary to closely observe the patient's response and assess the balance of benefits and risks.For patients who have achieved satisfactory results at a dose of 30 mg, there is no need to blindly pursue a higher dose.For patients who have obvious adverse reactions at a dose of 30 mg, they should consider reducing or discontinuing the drug, or try other treatment options.Through scientific dose titration, the occurrence of adverse reactions can be minimized while obtaining the best therapeutic effect.

The establishment of a dapoxetine treatment effect evaluation system requires a combination of standardized tools and personalized goals.The entries related to ejaculation control in the International erectile function score can be used as one of the evaluation tools, but the evaluation questionnaire specifically for premature ejaculation is more targeted.The pedigree tools of premature ejaculation include multiple dimensions such as ejaculation control score, ejaculation latent time, ejaculation-related pain score, and interpersonal communication difficulty score, which can fully reflect the impact of premature ejaculation on patients and the improvement brought about by treatment.During the treatment process, regular assessments should be carried out to record the trends in the scores of each dimension.The goal of treatment effect should be individualized. Some patients may pursue a significant extension of the latent time of ejaculation, while others may be more concerned about the improvement of ejaculation control or the reduction of psychological distress.Through the establishment of a scientific dose titration principle and treatment effect evaluation system, the personalized treatment of dapoxetine can be realized to meet the treatment needs of different patients.